Form 4: Vor Biopharma Executive Chakraborty Sells Shares to Cover Tax Obligations

Tirtha Chakraborty, Chief Scientific Officer of Vor Biopharma, sold 985 shares of common stock on August 1, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On August 1, 2024, Tirtha Chakraborty, the Chief Scientific Officer of Vor Biopharma Inc., disposed of 985 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations related to the settlement of restricted stock units.
• The shares were sold at a price of $0.94 per share.
• Following the transaction, Chakraborty directly owns 178,248 shares of Vor Biopharma Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a transaction to cover tax obligations, which is a routine event.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale to cover tax obligations.

Key Dates